Artelo Biosciences, Inc.
ARTL
$7.16
-$0.15-2.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -65.12% | -16.75% | 176.94% | -68.09% | -51.86% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.21% | -35.93% | -21.23% | -3.20% | 69.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -61.96% | -18.18% | 61.58% | -45.95% | -48.72% |
|
|
|||||
| Total Current Assets | -61.96% | -18.18% | 61.58% | -45.95% | -48.72% |
| Net Property, Plant & Equipment | -12.33% | -10.98% | -9.89% | -8.08% | -8.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -99.09% | 10,833.33% | 0.00% | 0.00% | 0.00% |
| Total Assets | -34.36% | -2.07% | 23.95% | -25.18% | -34.16% |
|
|
|||||
| Total Accounts Payable | -21.54% | -20.10% | 92.95% | 49.70% | 167.30% |
| Total Accrued Expenses | 360.26% | 77.27% | 91.30% | -62.30% | 69.44% |
| Short-term Debt | -30.40% | 10.62% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.56% | 8.33% | 0.00% | 2.86% | 2.94% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -16.79% | -14.92% | 103.71% | 58.24% | 154.23% |
|
|
|||||
| Total Current Liabilities | -16.79% | -14.92% | 103.71% | 58.24% | 154.23% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -30.40% | 10.62% | -- | -- | -- |
| Capital Leases | -27.50% | -21.57% | -13.56% | -14.49% | -11.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -16.88% | -14.97% | 101.29% | 55.51% | 137.55% |
|
|
|||||
| Common Stock & APIC | 6.02% | 7.09% | 2.31% | 0.36% | 0.49% |
| Retained Earnings | -7.08% | -5.60% | -6.13% | -4.73% | -8.15% |
| Treasury Stock & Other | 1.81% | 6.10% | -29.96% | -12.38% | 7.34% |
| Total Common Equity | -100.95% | 54.98% | -315.64% | -77.18% | -55.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -100.95% | 54.98% | -315.64% | -77.18% | -55.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -100.95% | 54.98% | -315.64% | -77.18% | -55.09% |
|
|
|||||